Baumann et al. [20] found two patients (33.33%) with Alagille syndrome who received 200 μg/kg of oral odevixibat had elevated ALT/AST levels that were present at baseline and persisted until the end of 4 weeks. Here, GPT is linked to Alagille syndrome.